Clover Health CEO, Medicare advantage, Jamie Reynoso sells $44,324 in CLOV shares
Clover Health CEO Jamie Reynoso sold 9,273 shares of the company's Class A Common Stock for a total of $44,324 on September 15, 2026. The transaction occurred to satisfy tax withholding obligations related to the vesting of his restricted stock units. At the time of the sale, Clover Health's stock was trading at $4.66, up 137% over the past six months.
Despite the stock being deemed overvalued by InvestingPro, Clover Health surpassed analysts' expectations for Q2 2026, reporting adjusted earnings of $0.05 per share and revenue of $743.2 million. The company has also raised its full-year guidance, signaling optimism for the future.
Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
